{"qas": [{"question": "Exercise-induced bronchoconstriction is common in what profession?", "id": "5728cc524b864d1900164e42", "answers": [{"text": "professional athletes", "answer_start": 207}], "is_impossible": false}, {"question": "What professions has the highest rate of Exercise-induced bronchoconstriction?", "id": "5728cc524b864d1900164e43", "answers": [{"text": "cyclists (up to 45%), swimmers, and cross-country skiers", "answer_start": 258}], "is_impossible": false}, {"question": "What conditions are more likely to cause Exercise-induced bronchoconstriction?", "id": "5728cc524b864d1900164e44", "answers": [{"text": "when it is dry and cold", "answer_start": 381}], "is_impossible": false}, {"question": "What does not appear to help athletic performance that do not have asthma?", "id": "5728cc524b864d1900164e45", "answers": [{"text": "Inhaled beta2-agonists", "answer_start": 406}], "is_impossible": false}, {"plausible_answers": [{"text": "bronchoconstriction", "answer_start": 21}], "question": "What does exercise trigger in people who use inhaled beta2 agonists?", "id": "5a501ab599b975001ade80c7", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "up to 20%", "answer_start": 121}], "question": "What percentage of people use inhaled beta2 agonists?", "id": "5a501ab599b975001ade80c8", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "cyclists", "answer_start": 258}], "question": "What group has the highest rate of inhaled beta2 agonist use?", "id": "5a501ab599b975001ade80c9", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "(up to 45%)", "answer_start": 267}], "question": "What percentage of cyclists used inhaled beta 2 agonists?", "id": "5a501ab599b975001ade80ca", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "professional athletes", "answer_start": 207}], "question": "What profession is asthma most common in?", "id": "5a501ab599b975001ade80cb", "answers": [], "is_impossible": true}], "context": "B\u00e0i t\u1eadp c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t <b4_0> co th\u1eaft ph\u1ebf qu\u1ea3n <b4_0/> c\u1ea3 \u1edf nh\u1eefng ng\u01b0\u1eddi c\u00f3 ho\u1eb7c kh\u00f4ng c\u00f3 b\u1ec7nh hen suy\u1ec5n. N\u00f3 x\u1ea3y ra \u1edf h\u1ea7u h\u1ebft m\u1ecdi ng\u01b0\u1eddi b\u1ecb hen suy\u1ec5n v\u00e0 <b5_0> l\u00ean \u0111\u1ebfn 20% <b5_0/> c\u1ee7a nh\u1eefng ng\u01b0\u1eddi kh\u00f4ng b\u1ecb hen suy\u1ec5n. T\u1eadp th\u1ec3 d\u1ee5c g\u00e2y co th\u1eaft ph\u1ebf qu\u1ea3n l\u00e0 ph\u1ed5 bi\u1ebfn \u1edf <a0_0><b8_0> v\u1eadn \u0111\u1ed9ng vi\u00ean chuy\u00ean nghi\u1ec7p <b8_0/><a0_0/> . T\u1ef7 l\u1ec7 cao nh\u1ea5t n\u1eb1m trong s\u1ed1 <a1_0><b6_0> ng\u01b0\u1eddi \u0111i xe \u0111\u1ea1p <b6_0/><b7_0> (l\u00ean \u0111\u1ebfn 45%) <b7_0/> , b\u01a1i l\u1ed9i v\u00e0 tr\u01b0\u1ee3t tuy\u1ebft b\u0103ng \u0111\u1ed3ng <a1_0/> . M\u1eb7c d\u00f9 n\u00f3 c\u00f3 th\u1ec3 x\u1ea3y ra v\u1edbi b\u1ea5t k\u1ef3 \u0111i\u1ec1u ki\u1ec7n th\u1eddi ti\u1ebft n\u00e0o ph\u1ed5 bi\u1ebfn h\u01a1n <a2_0> khi tr\u1eddi kh\u00f4 v\u00e0 l\u1ea1nh <a2_0/> . <a3_0> Thu\u1ed1c th\u1eed beta2-agonists <a3_0/> kh\u00f4ng xu\u1ea5t hi\u1ec7n \u0111\u1ec3 c\u1ea3i thi\u1ec7n hi\u1ec7u su\u1ea5t th\u1ec3 thao trong s\u1ed1 nh\u1eefng ng\u01b0\u1eddi kh\u00f4ng b\u1ecb hen suy\u1ec5n tuy nhi\u00ean li\u1ec1u u\u1ed1ng c\u00f3 th\u1ec3 c\u1ea3i thi\u1ec7n \u0111\u1ed9 b\u1ec1n v\u00e0 s\u1ee9c m\u1ea1nh."}